Lehrstuhl für Allgemeine Pathologie und Pathologische Anatomie

New oleoyl hybrids of natural antioxidants: Synthesis and in vitro evaluation as inducers of apoptosis in colorectal cancer cells (2020) Carullo G, Mazzotta S, Koch AM, Hartmann K, Friedrich O, Gilbert D, Vega-Holm M, et al. Journal article Tumour-infiltrating inflammatory cells in early breast cancer: An underrated prognostic and predictive factor? (2020) Schnellhardt S, Erber R, Büttner-Herold M, Rosahl MC, Ott O, Strnad V, Beckmann M, et al. Journal article Integrating Genomics and Clinical Data for Statistical Analysis by Using GEnome MINIng (GEMINI) and Fast Healthcare Interoperability Resources (FHIR): System Design and Implementation (2020) Gründner J, Wolf N, Tögel L, Haller F, Prokosch HU, Christoph J Journal article Piwi-like 1 and piwi-like 2 expression in breast cancer (2020) Erber R, Meyer J, Taubert H, Fasching P, Wach S, Häberle L, Gaß P, et al. Journal article Influence of the Family Anamnesis of Breast or Ovarian Cancer on the pathological Complete Remission and the Prognosis in Patients with Breast Cancer after neoadjuvant Chemotherapy (2020) Gaß P, Haberle L, Hein A, Jud S, Lux MP, Hack C, Emons J, et al. Conference contribution Accuracy of vulvoscopic findings in detecting early vulvar neoplasia (2020) Stuebs FA, Mehlhorn G, Gaß P, Schulmeyer C, Adler W, Strehl J, Hartmann A, et al. Conference contribution Assessment of the additional clinical potential of X-ray dark-field imaging for breast cancer in a preclinical setup (2020) Emons J, Fasching P, Wunderle M, Heindl F, Rieger J, Horn F, Pelzer G, et al. Conference contribution Accuracy of colposcopic findings in detecting vaginal intraepithelial neoplasia: a retrospective study (2020) Stuebs FA, Adler W, Beckmann M, Gaß P, Hartmann A, Mehlhorn G, Renner SK, et al. Conference contribution Mammographic Density and Prognosis in Patients with primary Breast Cancer - Loss of Risk with increasing Age (2020) Heindl F, Fasching P, Hein A, Hack C, Heusinger K, Gaß P, Schulz-Wendtland R, et al. Conference contribution Progression-free survival and overall survival in patients with advanced her2-positive breast cancer treated with trastuzumab emtansine (T-dm1) after previous treatment with pertuzumab (2020) Michel LL, Hartkopf AD, Fasching P, Kolberg HC, Hadji P, Tesch H, Häberle L, et al. Journal article